# Ventas, Inc. (VTR) · Edgar & Edgarette company card

> Ventas, Inc. (VTR) grew revenue 18.5% in FY2025 to $5.8 billion, equity 45.4% of assets, and dividend per share up 1 year running. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 740260 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/VTR) · [JSON](https://www.pops4.com/boards/company/VTR.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $5.8B |
| Revenue growth, 1 year | 18.5% |
| Revenue growth per year | 11.1% |
| Operating margin | — |
| Net margin | 4.5% |
| Operating cash flow | $1.6B |
| Capital spending | $2.9B |
| Free cash flow | −$1.3B |
| Cash | $741M |
| Long-term debt | $13.0B |
| Total assets | $27.6B |
| Total equity | $12.5B |
| Equity ÷ assets | 45.4% |
| Return on equity | 2.1% |
| Dividend per share | $1.92 |
| Dividend years rising | 1 |

## Readings, computed from those figures

- Piotroski F: 6 of 9 (solid)
- Health Harbor boat: Sound ship · one warning sign · free cash flow was negative: capital spending outran operating cash (-$1.3B in FY2025)
- Cash Compass: Cash cow now · steady, with strong cash arriving today

## Edgarette's reading

Exposure: revenue $5.8B (FY2025), total debt $13.0B. Experience: revenue up 18.5% on the year, up 11.1% a year over 4 years. Soundness: equity 45.4% of assets, return on equity 2.1%, payout 328.9% of profit, dividend per share up 1 year running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $6.0B and $7.2B next year (method v4.1: its own 4-year record of growth weighed at 50% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $5.6B to $7.8B. A statistical range, not company guidance. Against peers (79 filers, $50M+ revenue, real estate investment trusts): growth 18.5% against 3.7%.

Range logged 2026-09-24, receipt 35b9f6a6df8caa83, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 5, latest 2026-09-15 ([filing](https://www.sec.gov/Archives/edgar/data/740260/000110465926107921/0001104659-26-107921-index.htm))

## Recent filings

- 10-Q · filed 2026-10-28 · [filing](https://www.sec.gov/Archives/edgar/data/740260/000074026026000030/0000740260-26-000030-index.htm)
- 8-K · filed 2026-10-27 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/740260/000074026026000026/0000740260-26-000026-index.htm)
- 8-K · filed 2026-09-15 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/740260/000110465926107921/0001104659-26-107921-index.htm)
- 10-Q · filed 2026-07-30 · [filing](https://www.sec.gov/Archives/edgar/data/740260/000074026026000024/0000740260-26-000024-index.htm)
- 8-K · filed 2026-07-29 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/740260/000074026026000022/0000740260-26-000022-index.htm)
- 8-K · filed 2026-06-15 · 5.02 Departure or Election of Directors; Appointment of Officers; 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/740260/000110465926074016/0001104659-26-074016-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000740260.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=740260

## Cite

POPS4, Edgar & Edgarette: Ventas, Inc. (VTR) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/VTR. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.